Skip to Content

'
Milind Javle, M.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Unit Number: 426
Houston, TX 77030
Room Number: FC10.3062
Phone: 713-792-2828
Fax: 713-745-8620

Education & Training

Degree-Granting Education

1991 Grant Medical College, University of Bombay, India, Bombay, India, MD, Medicine

Postgraduate Training

1994-1995 Clinical Residency, Internal Medicine, SUNY Buffalo, Buffalo, NY

Experience/Service

Academic Appointments

Assistant Professor, Roswell Park Cancer Institute, Buffalo, NY, 10/2001-12/2006

Other Appointments/Responsibilities

Associate Member, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX, 9/2009-8/2010

Selected Publications

Peer-Reviewed Original Research Articles

1. Javle MM, Shroff RT, Xiong H, Varadhachary GA, Fogelman D, Reddy SA, Davis D, Zhang Y, Wolff RA, Abbruzzese JL. Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies. BMC Cancer 10:368, 2010. e-Pub 7/2010. PMCID: PMC2910694.
2. Javle M, Hsueh CT. Recent advances in gastrointestinal oncology--updates and insights from the 2009 annual meeting of the American Society of Clinical Oncology. J Hematol Oncol 3:11, 2010. e-Pub 3/2010. PMCID: PMC2856525.
3. Donthireddy KR, Ailawadhi S, Nasser E, Schiff MD, Nwogu CE, Nava HR, Javle MM. Malignant gastroparesis: pathogenesis and management of an underrecognized disorder. J Support Oncol 5(8):355-63, 9/2007. PMID: 17944143.

Grant & Contract Support

Title: Design, Synthesis and Evaluation of a Small Molecule Inhibitor of DNA Helicase RecQ1
Funding Source: The University of Texas MD Anderson Cancer Center
Role: Principal Investigator
Duration: 7/1/2011 - 6/30/2013
 
Title: Phase I Study of BikDD Nanoparticle for Advanced Cancer of the Pancreas
Funding Source: NCI-DHHS-NIH
Role: Principal Investigator
Duration: 4/14/2009 - 3/31/2014

Last updated: 8/15/2013